Postsurgical behavioral changes

Jay A Van Gerpen, John A Lucas, Julie A Fields

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease (Twelves D, Perkins KS, Counsell C. Mov Disord 18:19-31, 2003) and af flicts more than four million people worldwide (Dorsey ER, Constantinescu R, Thompson JP, et al. Neurology 68:384-386, 2007). Neurosurgical treatments for the debilitating symptoms of this movement disorder are implemented when medical therapy no longer provides sufficient benefit. Lesioning techniques initially utilized decades ago have been supplanted, for the most part, by deep brain stimulation (DBS) because of its potential reversibility should DBS prove to be unsuccessful or result in undue adverse events. Additionally, stimulation parameters can be adjusted as needed to optimize benefit (from both motor and neurobehavioral standpoints), and when bilateral procedures are necessary, DBS procedures are considered a safer alternative or adjunct to ablation. Stimulation of the subthalamic nucleus (STN) is currently the target of choice because it relieves most of the cardinal symptoms of PD and greatly reduces the amount of medication needed.

Original languageEnglish (US)
Title of host publicationParkinson's Disease and Nonmotor Dysfunction
Subtitle of host publicationSecond Edition
PublisherHumana Press Inc.
Pages91-117
Number of pages27
ISBN (Electronic)9781607614296
ISBN (Print)9781607614289
DOIs
StatePublished - Jan 1 2013

Fingerprint

Deep Brain Stimulation
Parkinson Disease
Subthalamic Nucleus
Movement Disorders
Neurology
Neurodegenerative Diseases
Therapeutics

Keywords

  • Cognition
  • Deep brain stimulation
  • Mood
  • Neurosurgery
  • Pallidal stimulation
  • Pallidotomy
  • Parkinson's disease
  • Psychiatric symptoms
  • Subthalamic stimulation
  • Subthalamotomy
  • Thalamic stimulation
  • Thalamotomy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Van Gerpen, J. A., Lucas, J. A., & Fields, J. A. (2013). Postsurgical behavioral changes. In Parkinson's Disease and Nonmotor Dysfunction: Second Edition (pp. 91-117). Humana Press Inc.. https://doi.org/10.1007/978-1-60761-429-6_6

Postsurgical behavioral changes. / Van Gerpen, Jay A; Lucas, John A; Fields, Julie A.

Parkinson's Disease and Nonmotor Dysfunction: Second Edition. Humana Press Inc., 2013. p. 91-117.

Research output: Chapter in Book/Report/Conference proceedingChapter

Van Gerpen, JA, Lucas, JA & Fields, JA 2013, Postsurgical behavioral changes. in Parkinson's Disease and Nonmotor Dysfunction: Second Edition. Humana Press Inc., pp. 91-117. https://doi.org/10.1007/978-1-60761-429-6_6
Van Gerpen JA, Lucas JA, Fields JA. Postsurgical behavioral changes. In Parkinson's Disease and Nonmotor Dysfunction: Second Edition. Humana Press Inc. 2013. p. 91-117 https://doi.org/10.1007/978-1-60761-429-6_6
Van Gerpen, Jay A ; Lucas, John A ; Fields, Julie A. / Postsurgical behavioral changes. Parkinson's Disease and Nonmotor Dysfunction: Second Edition. Humana Press Inc., 2013. pp. 91-117
@inbook{5520c8420a0249db9ccdeb19350d91a0,
title = "Postsurgical behavioral changes",
abstract = "Parkinson's disease (PD) is the second most common neurodegenerative disease (Twelves D, Perkins KS, Counsell C. Mov Disord 18:19-31, 2003) and af flicts more than four million people worldwide (Dorsey ER, Constantinescu R, Thompson JP, et al. Neurology 68:384-386, 2007). Neurosurgical treatments for the debilitating symptoms of this movement disorder are implemented when medical therapy no longer provides sufficient benefit. Lesioning techniques initially utilized decades ago have been supplanted, for the most part, by deep brain stimulation (DBS) because of its potential reversibility should DBS prove to be unsuccessful or result in undue adverse events. Additionally, stimulation parameters can be adjusted as needed to optimize benefit (from both motor and neurobehavioral standpoints), and when bilateral procedures are necessary, DBS procedures are considered a safer alternative or adjunct to ablation. Stimulation of the subthalamic nucleus (STN) is currently the target of choice because it relieves most of the cardinal symptoms of PD and greatly reduces the amount of medication needed.",
keywords = "Cognition, Deep brain stimulation, Mood, Neurosurgery, Pallidal stimulation, Pallidotomy, Parkinson's disease, Psychiatric symptoms, Subthalamic stimulation, Subthalamotomy, Thalamic stimulation, Thalamotomy",
author = "{Van Gerpen}, {Jay A} and Lucas, {John A} and Fields, {Julie A}",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/978-1-60761-429-6_6",
language = "English (US)",
isbn = "9781607614289",
pages = "91--117",
booktitle = "Parkinson's Disease and Nonmotor Dysfunction",
publisher = "Humana Press Inc.",

}

TY - CHAP

T1 - Postsurgical behavioral changes

AU - Van Gerpen, Jay A

AU - Lucas, John A

AU - Fields, Julie A

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Parkinson's disease (PD) is the second most common neurodegenerative disease (Twelves D, Perkins KS, Counsell C. Mov Disord 18:19-31, 2003) and af flicts more than four million people worldwide (Dorsey ER, Constantinescu R, Thompson JP, et al. Neurology 68:384-386, 2007). Neurosurgical treatments for the debilitating symptoms of this movement disorder are implemented when medical therapy no longer provides sufficient benefit. Lesioning techniques initially utilized decades ago have been supplanted, for the most part, by deep brain stimulation (DBS) because of its potential reversibility should DBS prove to be unsuccessful or result in undue adverse events. Additionally, stimulation parameters can be adjusted as needed to optimize benefit (from both motor and neurobehavioral standpoints), and when bilateral procedures are necessary, DBS procedures are considered a safer alternative or adjunct to ablation. Stimulation of the subthalamic nucleus (STN) is currently the target of choice because it relieves most of the cardinal symptoms of PD and greatly reduces the amount of medication needed.

AB - Parkinson's disease (PD) is the second most common neurodegenerative disease (Twelves D, Perkins KS, Counsell C. Mov Disord 18:19-31, 2003) and af flicts more than four million people worldwide (Dorsey ER, Constantinescu R, Thompson JP, et al. Neurology 68:384-386, 2007). Neurosurgical treatments for the debilitating symptoms of this movement disorder are implemented when medical therapy no longer provides sufficient benefit. Lesioning techniques initially utilized decades ago have been supplanted, for the most part, by deep brain stimulation (DBS) because of its potential reversibility should DBS prove to be unsuccessful or result in undue adverse events. Additionally, stimulation parameters can be adjusted as needed to optimize benefit (from both motor and neurobehavioral standpoints), and when bilateral procedures are necessary, DBS procedures are considered a safer alternative or adjunct to ablation. Stimulation of the subthalamic nucleus (STN) is currently the target of choice because it relieves most of the cardinal symptoms of PD and greatly reduces the amount of medication needed.

KW - Cognition

KW - Deep brain stimulation

KW - Mood

KW - Neurosurgery

KW - Pallidal stimulation

KW - Pallidotomy

KW - Parkinson's disease

KW - Psychiatric symptoms

KW - Subthalamic stimulation

KW - Subthalamotomy

KW - Thalamic stimulation

KW - Thalamotomy

UR - http://www.scopus.com/inward/record.url?scp=85028893837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028893837&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-429-6_6

DO - 10.1007/978-1-60761-429-6_6

M3 - Chapter

SN - 9781607614289

SP - 91

EP - 117

BT - Parkinson's Disease and Nonmotor Dysfunction

PB - Humana Press Inc.

ER -